These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 24105610)
21. Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. Svendsen KB; Jensen TS; Bach FW BMJ; 2004 Jul; 329(7460):253. PubMed ID: 15258006 [TBL] [Abstract][Full Text] [Related]
22. Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial. van den Elsen GA; Ahmed AI; Verkes RJ; Kramers C; Feuth T; Rosenberg PB; van der Marck MA; Olde Rikkert MG Neurology; 2015 Jun; 84(23):2338-46. PubMed ID: 25972490 [TBL] [Abstract][Full Text] [Related]
23. Olanzapine Versus Placebo in Adult Outpatients With Anorexia Nervosa: A Randomized Clinical Trial. Attia E; Steinglass JE; Walsh BT; Wang Y; Wu P; Schreyer C; Wildes J; Yilmaz Z; Guarda AS; Kaplan AS; Marcus MD Am J Psychiatry; 2019 Jun; 176(6):449-456. PubMed ID: 30654643 [TBL] [Abstract][Full Text] [Related]
24. Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial. Karst M; Salim K; Burstein S; Conrad I; Hoy L; Schneider U JAMA; 2003 Oct; 290(13):1757-62. PubMed ID: 14519710 [TBL] [Abstract][Full Text] [Related]
25. Effect of dronabinol on nutritional status in HIV infection. Struwe M; Kaempfer SH; Geiger CJ; Pavia AT; Plasse TF; Shepard KV; Ries K; Evans TG Ann Pharmacother; 1993; 27(7-8):827-31. PubMed ID: 8395916 [TBL] [Abstract][Full Text] [Related]
26. [Evaluation of perturbed body image in eating disorders using the Body Shape Questionnaire]. Lavoisy G; Guelfi JD; Vera L; Dardennes R; Rouillon F Encephale; 2008 Dec; 34(6):570-6. PubMed ID: 19081453 [TBL] [Abstract][Full Text] [Related]
27. Anorexia of aging in long term care: is dronabinol an effective appetite stimulant?--a pilot study. Wilson MM; Philpot C; Morley JE J Nutr Health Aging; 2007; 11(2):195-8. PubMed ID: 17435963 [TBL] [Abstract][Full Text] [Related]
28. Dronabinol increases pain threshold in patients with functional chest pain: a pilot double-blind placebo-controlled trial. Malik Z; Bayman L; Valestin J; Rizvi-Toner A; Hashmi S; Schey R Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26822791 [TBL] [Abstract][Full Text] [Related]
29. Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic Sclerosis. Spiera R; Hummers L; Chung L; Frech TM; Domsic R; Hsu V; Furst DE; Gordon J; Mayes M; Simms R; Lafyatis R; Martyanov V; Wood T; Whitfield ML; Constantine S; Lee E; Dgetluck N; White B Arthritis Rheumatol; 2020 Aug; 72(8):1350-1360. PubMed ID: 32336038 [TBL] [Abstract][Full Text] [Related]
30. Neuroleptics in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled study with sulpiride. Vandereycken W Br J Psychiatry; 1984 Mar; 144():288-92. PubMed ID: 6367876 [TBL] [Abstract][Full Text] [Related]
31. Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study. Mathai DS; Holst M; Rodgman C; Haile CN; Keller J; Hussain MZ; Kosten TR; Newton TF; Verrico CD J Neuropsychiatry Clin Neurosci; 2018; 30(1):66-76. PubMed ID: 28641496 [TBL] [Abstract][Full Text] [Related]
32. Intranasal oxytocin in the treatment of anorexia nervosa: Randomized controlled trial during re-feeding. Russell J; Maguire S; Hunt GE; Kesby A; Suraev A; Stuart J; Booth J; McGregor IS Psychoneuroendocrinology; 2018 Jan; 87():83-92. PubMed ID: 29049935 [TBL] [Abstract][Full Text] [Related]
33. Safety of oral dronabinol during opioid withdrawal in humans. Jicha CJ; Lofwall MR; Nuzzo PA; Babalonis S; Elayi SC; Walsh SL Drug Alcohol Depend; 2015 Dec; 157():179-83. PubMed ID: 26483357 [TBL] [Abstract][Full Text] [Related]
35. Tetrahydrocannabinol in Behavioral Disturbances in Dementia: A Crossover Randomized Controlled Trial. van den Elsen GAH; Ahmed AIA; Verkes RJ; Feuth T; van der Marck MA; Olde Rikkert MGM Am J Geriatr Psychiatry; 2015 Dec; 23(12):1214-1224. PubMed ID: 26560511 [TBL] [Abstract][Full Text] [Related]
36. Dronabinol for the treatment of agitation and aggressive behavior in acutely hospitalized severely demented patients with noncognitive behavioral symptoms. Woodward MR; Harper DG; Stolyar A; Forester BP; Ellison JM Am J Geriatr Psychiatry; 2014 Apr; 22(4):415-9. PubMed ID: 23597932 [TBL] [Abstract][Full Text] [Related]
37. Eating disorder symptoms and quality of life: where should clinicians place their focus in severe and enduring anorexia nervosa? Bamford B; Barras C; Sly R; Stiles-Shields C; Touyz S; Le Grange D; Hay P; Crosby R; Lacey H Int J Eat Disord; 2015 Jan; 48(1):133-8. PubMed ID: 25049195 [TBL] [Abstract][Full Text] [Related]
38. The effect of atypical antipsychotic medications in individuals with anorexia nervosa: a systematic review and meta-analysis. Lebow J; Sim LA; Erwin PJ; Murad MH Int J Eat Disord; 2013 May; 46(4):332-9. PubMed ID: 23001863 [TBL] [Abstract][Full Text] [Related]
39. The Impact of Δ9-THC on the Psychological Symptoms of Anorexia Nervosa: A Pilot Study. Avraham Y; Latzer Y; Hasid D; Berry EM Isr J Psychiatry; 2017; 54(3):44-51. PubMed ID: 29735812 [TBL] [Abstract][Full Text] [Related]
40. The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone. Bisaga A; Sullivan MA; Glass A; Mishlen K; Pavlicova M; Haney M; Raby WN; Levin FR; Carpenter KM; Mariani JJ; Nunes EV Drug Alcohol Depend; 2015 Sep; 154():38-45. PubMed ID: 26187456 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]